Voucher and NEW Patient Copay Assistance information is now available here

The 1st VMAT2 inhibitor approved for both TD and HD chorea1

For adults with TD or HD chorea

Make a move that matters


Educational resources to evolve
TD management


HD, Huntington’s disease; TD, tardive dyskinesia.

REFERENCE: 1. AUSTEDO® XR (deutetrabenazine) extended-release tablets and AUSTEDO® current Prescribing Information. Parsippany, NJ: Teva Neuroscience, Inc.